Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 193842

Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study


Vrdoljak, Eduard; Prskalo, Tomislav; Omrčen, Tomislav; Šitum, Kristina; Boraska, Tihana; Frleta Ilić, Nives; Janković, Stipan; Hamm, Wolfgang
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study // International journal of radiation oncology, biology, physics, 61 (2005), 824-829 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 193842 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study

Autori
Vrdoljak, Eduard ; Prskalo, Tomislav ; Omrčen, Tomislav ; Šitum, Kristina ; Boraska, Tihana ; Frleta Ilić, Nives ; Janković, Stipan ; Hamm, Wolfgang

Izvornik
International journal of radiation oncology, biology, physics (0360-3016) 61 (2005); 824-829

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
chemobrachytherapy; squamous cell carcinoma; cisplatin; cervix; ifosfamide

Sažetak
Purpose: To evaluate the efficacy and toxicity of ifosfamide and cisplatin administered concomitantly with low-dose-rate brachytherapy followed by consolidation chemotherapy in the treatment of locally advanced squamous cell cervical carcinoma (LASCC). Methods and Materials: Forty-four patients with biopsy-proven LASCC were enrolled. FIGO Stages 1132 bulky to IVA were entered into this study. Patients were assigned to receive external radiotherapy (50 Gy in 25 fractions) ; then ifosfamide 2 g/m(2) Plus cisplatin 75 mg/m(2) was applied during two low-dose-rate brachytherapy applications, and 4 cycles of consolidation chemotherapy with the same drug combination were given after completion of radiotherapy. The planned dose to point A was 85 Gy. Results: All patients received both courses of concomitant chemobrachytherapy and at least 1 cycle of consolidation chemotherapy. The average duration of radiation was 45.1 days. The clinical complete response rate was 100%. Grade 3 and 4 leukopenia occurred in 25 % and 11% of the cycles, respectively. After a median follow-up of 34 months (range, 20-54 months), the recurrence-free and the overall survival rates were 84% and 91%, respectively. Major delayed local complications occurred in 7 cases (16%). Conclusions: These results indicate that concomitant chemobrachyradiotherapy with ifosfamide and cisplatin is a feasible combination for patients with LASCC of the cervix uteri. A randomized trial is planned.

Izvorni jezik
Engleski



POVEZANOST RADA


Projekti:
0141009
0216014

Ustanove:
KBC Split


Citiraj ovu publikaciju:

Vrdoljak, Eduard; Prskalo, Tomislav; Omrčen, Tomislav; Šitum, Kristina; Boraska, Tihana; Frleta Ilić, Nives; Janković, Stipan; Hamm, Wolfgang
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study // International journal of radiation oncology, biology, physics, 61 (2005), 824-829 (međunarodna recenzija, članak, znanstveni)
Vrdoljak, E., Prskalo, T., Omrčen, T., Šitum, K., Boraska, T., Frleta Ilić, N., Janković, S. & Hamm, W. (2005) Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study. International journal of radiation oncology, biology, physics, 61, 824-829.
@article{article, author = {Vrdoljak, Eduard and Prskalo, Tomislav and Omr\v{c}en, Tomislav and \v{S}itum, Kristina and Boraska, Tihana and Frleta Ili\'{c}, Nives and Jankovi\'{c}, Stipan and Hamm, Wolfgang}, year = {2005}, pages = {824-829}, keywords = {chemobrachytherapy, squamous cell carcinoma, cisplatin, cervix, ifosfamide}, journal = {International journal of radiation oncology, biology, physics}, volume = {61}, issn = {0360-3016}, title = {Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study}, keyword = {chemobrachytherapy, squamous cell carcinoma, cisplatin, cervix, ifosfamide} }
@article{article, author = {Vrdoljak, Eduard and Prskalo, Tomislav and Omr\v{c}en, Tomislav and \v{S}itum, Kristina and Boraska, Tihana and Frleta Ili\'{c}, Nives and Jankovi\'{c}, Stipan and Hamm, Wolfgang}, year = {2005}, pages = {824-829}, keywords = {chemobrachytherapy, squamous cell carcinoma, cisplatin, cervix, ifosfamide}, journal = {International journal of radiation oncology, biology, physics}, volume = {61}, issn = {0360-3016}, title = {Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study}, keyword = {chemobrachytherapy, squamous cell carcinoma, cisplatin, cervix, ifosfamide} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font